Clinical Chemistry and Laboratory Medicine (CCLM) · 2008 · 75 citations · 30 references
Veterinary MedicineBiochemistryPathologyClinical BiochemistryInflammationSepsisBiomarkers In PathologyBiomarkers In SepsisBiomarkers Of Liver InjuryInflammatory BiomarkersMetabolic InflammationPlasma ProteinsBiomarker CorrelationC-reactive Protein TestingInflammation In Cardiovascular DiseaseSepsis-associated InflammationSystemic Inflammation Markers
BACKGROUND: Alkaline phosphatase (ALP) is a biomarker for hepatobiliary and skeletal diseases. It is also raised in sepsis. In atherosclerotic plaques, ALP is expressed. Similar to C-reactive protein (CRP), it may be another marker of systemic inflammation. Therefore, we investigated their association in a Hong Kong Chinese population. METHODS: Plasma ALP and CRP were measured in 205 subjects (110 men, 95 women; age 55.2+/-11.6 years) in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 cohort. RESULTS: The blood levels of ALP and CRP were significantly correlated (r=0.30, p<0.001), which was due to a significant correlation in women (r=0.43, p<0.001). In a multivariate model, CRP level was related to ALP (beta=0.18, p=0.008). After adjusting for confounding factors and other liver enzymes, the relationship between ALP and CRP remained significant in women (beta=0.28, p=0.019), but in men, ALP was not an independent determinant of CRP levels. CONCLUSIONS: ALP may be another marker of systemic inflammation, especially in women. Whether it provides clinical information additional to CRP requires further study.
30
John Yudkin, Coen D.A. Stehouwer, J.J. Emeis et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 2.5K citations · Full text
The Insulin Resistance Atherosclerosis Study (IRAS)
Lynne E. Wagenknecht, Elizabeth J Mayer, Marian Rewers et al. · Annals of Epidemiology · 1995 · 494 citations
Medicine, Cardiology, Endocrinology +11